Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stroke

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 124 articles:
HTML format



Single Articles


    June 2022
  1. TAO C, Qureshi AI, Yin Y, Li J, et al
    Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
    Circulation. 2022 Jun 3:101161CIRCULATIONAHA121058544.
    PubMed     Abstract available


    April 2022
  2. NATALE A, Kar S, Holmes D
    Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e847-e848.
    PubMed    


  3. PRICE MJ, Gibson DN, Kar S
    Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e849.
    PubMed    


  4. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e845-e846.
    PubMed    


  5. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
    Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
    Circulation. 2022;145:1254-1284.
    PubMed     Abstract available


  6. VASAN RS, Enserro DM, Xanthakis V, Beiser AS, et al
    Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
    Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057889.
    PubMed     Abstract available


  7. SPYROPOULOS AC, Raskob GE, Cohen AT, Ageno W, et al
    Association of Bleeding Severity with Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
    Circulation. 2022 Apr 7. doi: 10.1161/CIRCULATIONAHA.121.057847.
    PubMed     Abstract available


    March 2022
  8. BORLAUG BA, Blair J, Bergmann MW, Bugger H, et al
    Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
    Circulation. 2022 Mar 31. doi: 10.1161/CIRCULATIONAHA.122.059486.
    PubMed     Abstract available


  9. JOUNDI RA, Sun JL, Xian Y, Alhanti B, et al
    Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion.
    Circulation. 2022;145:896-905.
    PubMed     Abstract available


  10. LI KC, Huang L, Tian M, Di Tanna GL, et al
    Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS).
    Circulation. 2022 Mar 21. doi: 10.1161/CIRCULATIONAHA.122.059573.
    PubMed     Abstract available


  11. KOWALEWSKI C, Dagres N, Hindricks G
    Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial.
    Circulation. 2022;145:739-741.
    PubMed    


  12. LUBITZ SA, Atlas SJ, Ashburner JM, Trisini Lipsanopoulos AT, et al
    Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial.
    Circulation. 2022 Mar 2. doi: 10.1161/CIRCULATIONAHA.121.057014.
    PubMed     Abstract available


    February 2022
  13. HAUSLER KG, Eichner FA, Heuschmann PU, Fiebach JB, et al
    MRI-Detected Brain Lesions and Cognitive Function in Atrial Fibrillation Patients Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial.
    Circulation. 2022 Feb 9. doi: 10.1161/CIRCULATIONAHA.121.056320.
    PubMed     Abstract available


    January 2022
  14. TSAO CW, Aday AW, Almarzooq ZI, Alonso A, et al
    Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
    Circulation. 2022 Jan 26:CIR0000000000001052. doi: 10.1161/CIR.0000000000001052.
    PubMed     Abstract available


  15. AGUADO BA, Walker CJ, Grim JC, Schroeder ME, et al
    Genes that Escape X Chromosome Inactivation Modulate Sex Differences in Valve Myofibroblasts.
    Circulation. 2022 Jan 10. doi: 10.1161/CIRCULATIONAHA.121.054108.
    PubMed     Abstract available


    December 2021
  16. BAHNSON TD, Giczewska A, Mark DB, Russo AM, et al
    Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.
    Circulation. 2021 Dec 22. doi: 10.1161/CIRCULATIONAHA.121.055297.
    PubMed     Abstract available


  17. ZHENG F, von Spreckelsen N, Hu W
    Letter by Zheng et al Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e491-e492.
    PubMed    


  18. TRIFAN G, Gorelick PB, Testai FD
    Response by Trifan et al to Letter Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e493-e494.
    PubMed    


    November 2021
  19. HANKEY GJ
    Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?
    Circulation. 2021;144:1747-1749.
    PubMed    


  20. KIRCHHOF P
    In Patients With Recently Diagnosed Atrial Fibrillation, Think Anticoagulation and Rhythm Control.
    Circulation. 2021;144:1587-1589.
    PubMed    


    October 2021
  21. VERMA S, Bhatt DL, Steg PG, Miller M, et al
    Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
    PubMed     Abstract available


  22. MAJITHIA A, Bhatt DL, Friedman AN, Miller M, et al
    Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients with Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.055560.
    PubMed     Abstract available


  23. KHAN SU, Javed Z, Lone AN, Dani SS, et al
    Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018.
    Circulation. 2021;144:1272-1279.
    PubMed     Abstract available


  24. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    PubMed     Abstract available


  25. HESS CN, Debus ES, Nehler MR, Anand SS, et al
    Reduction in Acute Limb Ischemia with Rivaroxaban versus Placebo in Peripheral Artery Disease after Lower Extremity Revascularization: Insights from VOYAGER PAD.
    Circulation. 2021 Oct 12. doi: 10.1161/CIRCULATIONAHA.121.055146.
    PubMed     Abstract available


    September 2021
  26. CHO SM, Mehaffey JH, Meyers SL, Cantor RS, et al
    Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Circulation. 2021;144:763-772.
    PubMed     Abstract available


    August 2021
  27. LAKKIREDDY D, Thaler D, Ellis CR, Swarup V, et al
    AMPLATZER AMULET LEFT ATRIAL APPENDAGE OCCLUDER VERSUS WATCHMAN DEVICE FOR STROKE PROPHYLAXIS (AMULET IDE): A RANDOMIZED CONTROLLED TRIAL.
    Circulation. 2021 Aug 30. doi: 10.1161/CIRCULATIONAHA.121.057063.
    PubMed     Abstract available


  28. LACKEY LG, Garnett CE, Senatore F
    Applying Decision Analysis to Inform the US Food and Drug Administration's Benefit-Risk Assessment of Ticagrelor for Primary Prevention of Myocardial Infarction or Stroke Based on THEMIS.
    Circulation. 2021;144:655-658.
    PubMed    


  29. DEBUS ES, Nehler MR, Govsyeyev N, Bauersachs RM, et al
    Effect of Rivaroxaban and Aspirin in Patients with Peripheral Artery Disease Undergoing Surgical Revascularization: Insights from the VOYAGER PAD Trial.
    Circulation. 2021 Aug 12. doi: 10.1161/CIRCULATIONAHA.121.054835.
    PubMed     Abstract available


    July 2021
  30. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
    Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
    Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
    PubMed     Abstract available


    May 2021
  31. CRUMP C, Sundquist J, Sundquist K
    Preterm Delivery and Long-Term Risk of Stroke in Women: A National Cohort and Cosibling Study.
    Circulation. 2021 May 10. doi: 10.1161/CIRCULATIONAHA.120.052268.
    PubMed    


    April 2021
  32. TRIFAN G, Gorelick PB, Testai FD
    Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Circulation. 2021 Apr 30. doi: 10.1161/CIRCULATIONAHA.121.053782.
    PubMed     Abstract available


  33. BENESCH C, Glance LG, Derdeyn CP, Fleisher LA, et al
    Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association.
    Circulation. 2021 Apr 8:CIR0000000000000968. doi: 10.1161/CIR.0000000000000968.
    PubMed     Abstract available


  34. KAR S, Doshi SK, Sadhu A, Horton R, et al
    Primary Outcome Evaluation of a Next Generation Left Atrial Appendage Closure Device: Results from the PINNACLE FLX Trial.
    Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.120.050117.
    PubMed     Abstract available


  35. DOUMOURAS A, Wong JA, Paterson JM, Lee Y, et al
    Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study.
    Circulation. 2021 Apr 5. doi: 10.1161/CIRCULATIONAHA.120.052386.
    PubMed    


    March 2021
  36. SALEH C
    Letter by Saleh Regarding Article, "Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin".
    Circulation. 2021;143:e790-e791.
    PubMed    


    February 2021
  37. BUTALA NM, Makkar R, Secemsky EA, Gallup D, et al
    Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results from the TVT Registry.
    Circulation. 2021 Feb 23. doi: 10.1161/CIRCULATIONAHA.120.052874.
    PubMed     Abstract available


  38. GOFF DC JR, Khan SS, Lloyd-Jones D, Arnett DK, et al
    Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
    Circulation. 2021;143:837-851.
    PubMed     Abstract available


  39. ELGENDY IY, Bukhari S, Barakat AF, Pepine CJ, et al
    Maternal Stroke: A Call for Action.
    Circulation. 2021;143:727-738.
    PubMed     Abstract available


  40. RAGHUNATH S, Pfeifer JM, Ulloa-Cerna AE, Nemani A, et al
    Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead Electrocardiogram and Help Identify Those at Risk of AF-Related Stroke.
    Circulation. 2021 Feb 16. doi: 10.1161/CIRCULATIONAHA.120.047829.
    PubMed    


    January 2021
  41. VIRANI SS, Alonso A, Aparicio HJ, Benjamin EJ, et al
    Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
    Circulation. 2021 Jan 27:CIR0000000000000950. doi: 10.1161/CIR.0000000000000950.
    PubMed     Abstract available


  42. BENJAMIN EJ, Go AS, Desvigne-Nickens P, Anderson CD, et al
    Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.
    Circulation. 2021;143:372-388.
    PubMed     Abstract available


  43. HIJAZI Z, Alexander JH, Li Z, Wojdyla DM, et al
    Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.
    Circulation. 2021 Jan 19. doi: 10.1161/CIRCULATIONAHA.120.051020.
    PubMed     Abstract available


  44. LI W, Kessinger CW, Orii M, Lee H, et al
    Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.
    Circulation. 2021 Jan 15. doi: 10.1161/CIRCULATIONAHA.120.049096.
    PubMed     Abstract available


  45. SCHWARTZ GG, Steg PG, Bhatt DL, Bittner VA, et al
    Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
    Circulation. 2021 Jan 13. doi: 10.1161/CIRCULATIONAHA.120.049447.
    PubMed     Abstract available


    December 2020
  46. KATSANOS AH, Kamel H, Healey JS, Hart RG, et al
    Stroke Prevention in Atrial Fibrillation: Looking Forward.
    Circulation. 2020;142:2371-2388.
    PubMed     Abstract available


  47. CHURCHWELL K, Elkind MSV, Benjamin RM, Carson AP, et al
    Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association.
    Circulation. 2020;142:e454-e468.
    PubMed     Abstract available


  48. SOGAARD M, Nielsen PB, Skjoth F, Eldrup N, et al
    Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
    Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.047994.
    PubMed     Abstract available


  49. SAFFORD MM, Reshetnyak E, Sterling MR, Richman JS, et al
    Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.048026.
    PubMed     Abstract available


    November 2020
  50. MARSTON NA, Patel PN, Kamanu FK, Nordio F, et al
    Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease.
    Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.051927.
    PubMed     Abstract available


    October 2020
  51. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
    Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
    PubMed     Abstract available


  52. LOWENSTEIN CJ, Solomon SD
    Severe COVID-19 Is a Microvascular Disease.
    Circulation. 2020;142:1609-1611.
    PubMed    


  53. MODIN D, Claggett B, Sindet-Pedersen C, Lassen MCH, et al
    Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.050809.
    PubMed    


  54. TAMBURINO C, Bleiziffer S, Thiele H, Scholtz S, et al
    Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051547.
    PubMed     Abstract available


  55. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1320-1329.
    PubMed     Abstract available


  56. DROBNI ZD, Alvi RM, Taron J, Zafar A, et al
    Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque.
    Circulation. 2020 Oct 2. doi: 10.1161/CIRCULATIONAHA.120.049981.
    PubMed     Abstract available


    August 2020
  57. GAUDINO M, Benesch C, Bakaeen F, DeAnda A, et al
    Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Aug 26:CIR0000000000000885. doi: 10.1161/CIR.0000000000000885.
    PubMed     Abstract available


  58. BUTT JH, Fosbol EL, Ostergaard L, Yafasova A, et al
    The Impact of Coronavirus Disease 2019 (COVID-19) on First-time Acute Stroke and Transient Ischemic Attack Admission Rates and Prognosis in Denmark: A Nationwide Cohort Study.
    Circulation. 2020 Aug 5. doi: 10.1161/CIRCULATIONAHA.120.050173.
    PubMed    


    July 2020
  59. LIBERALE L, Bonetti NR, Puspitasari YM, Schwarz L, et al
    Postischemic Administration of IL-1alpha Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke.
    Circulation. 2020;142:187-189.
    PubMed    


    June 2020
  60. AMARENCO P, Hobeanu C, Labreuche J, Charles H, et al
    Carotid Atherosclerosis Evolution when Targeting a Low-Density Lipoprotein Cholesterol Concentration < 70 mg/dL after an Ischemic Stroke of Atherosclerotic Origin.
    Circulation. 2020 Jun 29. doi: 10.1161/CIRCULATIONAHA.120.046774.
    PubMed     Abstract available


  61. WILLEIT P, Tschiderer L, Allara E, Reuber K, et al
    Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100,667 Patients.
    Circulation. 2020 Jun 17. doi: 10.1161/CIRCULATIONAHA.120.046361.
    PubMed     Abstract available


  62. LEE H, Yano Y, Cho SMJ, Park JH, et al
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.
    PubMed     Abstract available


    May 2020
  63. YANG L, Han B, Zhang Z, Wang S, et al
    Extracellular Vesicle-Mediated Delivery of CircSCMH1 Promotes Functional Recovery in Rodent and Nonhuman Primate Ischemic Stroke Models.
    Circulation. 2020 May 22. doi: 10.1161/CIRCULATIONAHA.120.045765.
    PubMed     Abstract available


  64. POTHINENI NVK, Deo R
    Screening for Atrial Fibrillation: Closing the "LOOP".
    Circulation. 2020;141:1523-1526.
    PubMed    


    April 2020
  65. BETHEL MA, Stevens SR, Buse JB, Choi J, et al
    Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes.
    Circulation. 2020;141:1360-1370.
    PubMed     Abstract available


  66. CAINZOS-ACHIRICA M, Miedema MD, McEvoy JW, Al Rifai M, et al
    Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2020 Apr 1. doi: 10.1161/CIRCULATIONAHA.119.045010.
    PubMed     Abstract available


    March 2020
  67. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
    The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
    PubMed     Abstract available


  68. KAPLAN RM, Ziegler PD, Passman RS
    Response by Kaplan et al to Letter Regarding Article, "Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score".
    Circulation. 2020;141:e599-e600.
    PubMed    


  69. CAO S, Zhu X, Xia M
    Letter by Cao et al Regarding Article, "Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score".
    Circulation. 2020;141:e597-e598.
    PubMed    


  70. DIEDERICHSEN SZ, Haugan KJ, Kronborg C, Graff C, et al
    A Comprehensive Evaluation of Rhythm Monitoring Strategies in Screening for Atrial Fibrillation: Insights from Patients at Risk Long-Term Monitored with Implantable Loop Recorder.
    Circulation. 2020 Mar 2. doi: 10.1161/CIRCULATIONAHA.119.044407.
    PubMed     Abstract available


    February 2020
  71. KHOSROW-KHAVAR F, Filion KB, Bouganim N, Suissa S, et al
    Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study.
    Circulation. 2020;141:549-559.
    PubMed     Abstract available


  72. HARRINGTON RA, Califf RM, Balamurugan A, Brown N, et al
    Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association.
    Circulation. 2020 Feb 10:CIR0000000000000753. doi: 10.1161/CIR.0000000000000753.
    PubMed     Abstract available


  73. BHATT DL, Miller M, Brinton EA, Jacobson TA, et al
    REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
    Circulation. 2020;141:367-375.
    PubMed     Abstract available


    January 2020
  74. VIRANI SS, Alonso A, Benjamin EJ, Bittencourt MS, et al
    Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
    Circulation. 2020 Jan 29:CIR0000000000000757. doi: 10.1161/CIR.0000000000000757.
    PubMed     Abstract available


    November 2019
  75. SCHNABEL RB, Haeusler KG, Healey JS, Freedman B, et al
    Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.
    Circulation. 2019;140:1834-1850.
    PubMed     Abstract available


  76. JIA X, Sun W, Hoogeveen RC, Nambi V, et al
    Response by Jia et al to Letter Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study".
    Circulation. 2019;140:e772-e773.
    PubMed    


  77. LI D, Cheng Y
    Letter by Li and Cheng Regarding Article, "High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study".
    Circulation. 2019;140:e770-e771.
    PubMed    


  78. MICHOS ED, Martin SS
    Achievement of Very Low Low-Density Lipoprotein Cholesterol Levels: Is It Time to Unlearn Concern for Hemorrhagic Stroke?
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044275.
    PubMed    


  79. JUKEMA JW, Zijlstra LE, Bhatt DL, Bittner VA, et al
    Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043826.
    PubMed    


    September 2019
  80. KAPLAN RM, Koehler J, Ziegler PD, Sarkar S, et al
    Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score.
    Circulation. 2019 Sep 30. doi: 10.1161/CIRCULATIONAHA.119.041303.
    PubMed     Abstract available


  81. WATANABE H, Domei T, Morimoto T, Natsuaki M, et al
    Very Short Dual Antiplatelet Therapy after Drug-eluting Stent Implantation in Patients with High Bleeding Risk: Insight from the STOPDAPT-2 Trial.
    Circulation. 2019 Sep 27. doi: 10.1161/CIRCULATIONAHA.119.043613.
    PubMed     Abstract available


  82. NOLAN JP, Berg RA, Andersen LW, Bhanji F, et al
    Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: Update of the Utstein Resuscitation Registry Template for In-Hospital Cardiac Arrest: A Consensus Report From a Task Force of the International Liaison Committee on Resuscitation (Ameri
    Circulation. 2019 Sep 16:CIR0000000000000710. doi: 10.1161/CIR.0000000000000710.
    PubMed     Abstract available


  83. PLUMP A, Davey Smith G
    Identifying and Validating New Drug Targets for Stroke and Beyond.
    Circulation. 2019;140:831-835.
    PubMed    


    August 2019
  84. SVEDBERG N, Sundstrom J, James S, Hallmarker U, et al
    Long-Term Incidence of Atrial Fibrillation and Stroke Among Cross-Country Skiers: Cohort Study of Endurance-Trained Male and Female Athletes.
    Circulation. 2019 Aug 26. doi: 10.1161/CIRCULATIONAHA.118.039461.
    PubMed    


  85. PACKER M
    Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events.
    Circulation. 2019;140:443-445.
    PubMed    


    July 2019
  86. MEHRA MR, Colombo PC
    Response by Mehra and Colombo to Letter Regarding Article, "Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the Heartmate 3 Versus the Heartmate II Cardiac Pump".
    Circulation. 2019;140:e165-e166.
    PubMed    


  87. CONSOLO F, Pappalardo F
    Letter by Consolo and Pappalardo Regarding Article, "Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the Heartmate 3 Versus the Heartmate II Cardiac Pump".
    Circulation. 2019;140:e163-e164.
    PubMed    


    June 2019
  88. CHONG M, Sjaarda J, Pigeyre M, Mohammadi-Shemirani P, et al
    Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
    Circulation. 2019 Jun 18. doi: 10.1161/CIRCULATIONAHA.119.040180.
    PubMed     Abstract available


    April 2019
  89. WANG TY
    Effectively Initiating and Maintaining Anticoagulation in Patients With Atrial Fibrillation.
    Circulation. 2019;139:1763-1765.
    PubMed    


    March 2019
  90. SHAH S, Xian Y, Sheng S, Zachrison KS, et al
    Use, Temporal Trends, and Outcomes of Endovascular Therapy After Interhospital Transfer in the United States.
    Circulation. 2019;139:1568-1577.
    PubMed     Abstract available


    February 2019
  91. NAFEE T, Gibson CM, Yee MK, Kerneis M, et al
    Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.
    Circulation. 2019;139:1234-1236.
    PubMed    


  92. HANKEY GJ
    Antithrombotic Therapy for Stroke Prevention.
    Circulation. 2019;139:1131-1133.
    PubMed    


  93. CHUNG J, Stevens LM, Ouzounian M, El-Hamamsy I, et al
    Sex-Related Differences in Patients Undergoing Thoracic Aortic Surgery.
    Circulation. 2019;139:1177-1184.
    PubMed     Abstract available


  94. HYLEK EM
    Biomarkers for Prediction of Stroke and Bleeds in Atrial Fibrillation.
    Circulation. 2019;139:772-774.
    PubMed    


    January 2019
  95. PICCINI JP, Xu H, Cox M, Matsouaka RA, et al
    Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).
    Circulation. 2019 Jan 31. doi: 10.1161/CIRCULATIONAHA.118.035909.
    PubMed     Abstract available


  96. BENJAMIN EJ, Muntner P, Alonso A, Bittencourt MS, et al
    Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
    Circulation. 2019 Jan 31:CIR0000000000000659. doi: 10.1161/CIR.0000000000000659.
    PubMed    


  97. SHARMA M, Hart RG, Connolly SJ, Bosch J, et al
    Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.035864.
    PubMed     Abstract available


  98. OKAZAKI S, Morimoto T, Kamatani Y, Kamimura T, et al
    Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis.
    Circulation. 2019;139:295-298.
    PubMed    


  99. SCHWAMM LH
    Digital Health Strategies to Improve Care and Continuity Within Stroke Systems of Care in the United States.
    Circulation. 2019;139:149-151.
    PubMed    


    December 2018
  100. MANN JFE, Fonseca V, Mosenzon O, Raz I, et al
    Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Circulation. 2018;138:2908-2918.
    PubMed     Abstract available


  101. VERMA S, Poulter NR, Bhatt DL, Bain SC, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
    Circulation. 2018;138:2884-2894.
    PubMed     Abstract available


  102. DIDIER R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, et al
    Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients.
    Circulation. 2018;138:2597-2607.
    PubMed     Abstract available


  103. KIM MK, Han K, Park YM, Kwon HS, et al
    Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
    Circulation. 2018;138:2627-2637.
    PubMed     Abstract available


    November 2018
  104. SAVITZ SI, Yavagal D, Rappard G, Likosky W, et al
    A Phase 2 Randomized, Sham Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow Derived ALD-401 Cells in Patients with Recent Stable Ischemic Stroke (RECOVER-Stroke).
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.117.030659.
    PubMed     Abstract available


  105. BASSAND JP, Virdone S, Goldhaber SZ, Camm AJ, et al
    Early Risks of Death, Stroke/Systemic Embolism and Major Bleeding in Patients with Newly Diagnosed Atrial Fibrillation: Results from the GARFIELD-AF Registry.
    Circulation. 2018 Nov 28. doi: 10.1161/CIRCULATIONAHA.118.035012.
    PubMed     Abstract available


  106. BERG DD, Ruff CT, Jarolim P, Giugliano RP, et al
    Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients with Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038312.
    PubMed     Abstract available


  107. ROCHA RV, Tam DY, Karkhanis R, Nedadur R, et al
    Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients.
    Circulation. 2018;138:2081-2090.
    PubMed     Abstract available


    October 2018
  108. DI BIASE L, Natale A, Romero J
    Thrombogenic and Arrhythmogenic Roles of the Left Atrial Appendage in Atrial Fibrillation.
    Circulation. 2018;138:2036-2050.
    PubMed     Abstract available


  109. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
    Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Circulation. 2018;138:1819-1827.
    PubMed     Abstract available


  110. CHAO TF, Chiang CE, Lin YJ, Chang SL, et al
    Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan.
    Circulation. 2018;138:1485-1487.
    PubMed    


  111. MAHESHWARI A, Norby FL, Roetker NS, Soliman EZ, et al
    Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score: The Atherosclerosis Risk in Communities (ARIC) Study and Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2018 Oct 2. doi: 10.1161/CIRCULATIONAHA.118.035411.
    PubMed     Abstract available


    September 2018
  112. DAWSON J
    Pioglitazone Use After Stroke.
    Circulation. 2018;138:1221-1223.
    PubMed    


  113. KOH KK
    Letter by Koh Regarding Article, "PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)".
    Circulation. 2018;138:1283-1284.
    PubMed    


  114. DE VEER AJWM, Bennaghmouch N, Mahmoodi BK, Ten Berg JM, et al
    Response by de Veer et al to Letter Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Tria
    Circulation. 2018;138:1279.
    PubMed    


  115. TONG S, Zhang L, Joseph J
    Letter by Tong et al Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials".
    Circulation. 2018;138:1277-1278.
    PubMed    


  116. COLOMBO PC, Mehra MR, Goldstein DJ, Estep JD, et al
    Comprehensive Analysis of Stroke in the LongTerm Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the HeartMate 3 Versus the HeartMate II Cardiac Pump.
    Circulation. 2018 Sep 17. doi: 10.1161/CIRCULATIONAHA.118.037231.
    PubMed     Abstract available


    July 2018
  117. SHEN YM, Nagalla S
    Hypercoagulable Workup in Thrombotic Cardiovascular Diseases.
    Circulation. 2018;138:229-231.
    PubMed    


    June 2018
  118. YOUNG LH, Viscoli CM, Schwartz GG, Inzucchi SE, et al
    Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone.
    Circulation. 2018 Jun 22. pii: CIRCULATIONAHA.118.034763.
    PubMed     Abstract available


  119. SHARMA A, Hijazi Z, Andersson U, Al-Khatib SM, et al
    The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial.
    Circulation. 2018 Jun 5. pii: CIRCULATIONAHA.118.034125.
    PubMed     Abstract available


    May 2018
  120. MEHRA MR, Salerno C, Cleveland JC, Pinney S, et al
    Health Care Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study: A Randomized Controlled Trial of a Magnetically Levitated Cardiac Pump in Advanced Heart Failure.
    Circulation. 2018 May 27. pii: CIRCULATIONAHA.118.035722.
    PubMed     Abstract available


  121. NAZHA B, Pandya B, Cohen J, Zhang M, et al
    Periprocedural Outcomes of Direct Oral Anticoagulants vs. Warfarin in Non-Valvular Atrial Fibrillation: A Meta-analysis of Phase III Trials.
    Circulation. 2018 May 24. pii: CIRCULATIONAHA.117.031457.
    PubMed     Abstract available


    April 2018
  122. O'BRIEN EC, Holmes DN, Thomas LE, Fonarow GC, et al
    Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients with Atrial Fibrillation.
    Circulation. 2018 Apr 20. pii: CIRCULATIONAHA.117.031354.
    PubMed     Abstract available


    March 2018
  123. BEHESHTI S, Madsen CM, Varbo A, Benn M, et al
    Relationship of Familial Hypercholesterolemia and High LDL Cholesterol to Ischemic Stroke: The Copenhagen General Population Study.
    Circulation. 2018 Mar 28. pii: CIRCULATIONAHA.118.033470.
    PubMed     Abstract available


    February 2018
  124. CHAO TF, Liu CJ, Lin YJ, Chang SL, et al
    Oral Anticoagulation in Very Elderly Patients with Atrial Fibrillation - A Nationwide Cohort Study.
    Circulation. 2018 Feb 28. pii: CIRCULATIONAHA.117.031658.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: